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Abstract
Background: Although Latinos, African-Americans, and American Indians/Alaska Natives comprise 34% of Americans,
these under-represented minorities (URMs) account for only 7% of US medical-school faculty. Even when URMs
become faculty, they face many substantial challenges to success. Little has been published, however, on keys to
academic success for URM young faculty investigators.
Methods: The Research in Academic Pediatrics Initiative on Diversity (RAPID) goal is to enhance the professional
advancement of URM junior faculty pursuing research careers in general academic pediatrics. One important RAPID
component is the annual mentoring/career-development conference, which targets URM residents, fellows, and junior
faculty, and has included 62 URM participants since its 2013 inception. A conference highlight is the panel discussion on
keys to academic success for URM young investigators, conducted by the RAPID National Advisory Committee, a diverse
group of leading senior researchers. The article aim was to provide a guide to academic success for URM young
investigators using the 2018 RAPID Conference panel discussion. A modified Delphi technique was used to provide a
systematic approach to obtaining answers to six key questions using an expert panel: the single most important key to
success for URM young investigators; ensuring optimal mentorship; how to respond when patients/families say, “I don’t
want you to see my child because you are ____”; best strategies for maximizing funding success; how to balance serving
on time-consuming committees with enough time to advance research/career objectives; and the single thing you wish
someone had told you which would have substantially enhanced your success early on.
Results/Conclusions: This is the first published practical guide on keys to academic success for URM young
investigators. Identified keys to success included having multiple mentors, writing prolifically, being tenaciously
persistent, having mentors who are invested in you, dealing with families who do not want you to care for their child
because of your race/ethnicity by seeking to understand the reasons and debriefing with colleagues, seeking
non-traditional funding streams, balancing committee work with having enough time to advance one’s research and
career by using these opportunities to generate scholarly products, and asking for all needed resources when
negotiating for new jobs.
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Background
Certain racial/ethnic minority groups continue to be
under-represented in academic medicine in the US. Al-
though Latinos, African-Americans, American Indians/Al-
aska Natives, and Native Hawaiians/other Pacific Islanders
comprise 34% of the US population [1], these under-
represented minorities (URMs) account for only 7% of US
medical-school faculty [2]. Even when URMs become US
medical-school faculty, they face many substantial chal-
lenges to success, including a significantly lower probabil-
ity of receiving National Institutes of Health (NIH)
investigator-initiated research funding [3], about half the
likelihood of receiving a mentored NIH K career-
development award [4], and obstacles to achieving success
in academic medicine, including negotiating for protected
research time, how “non-academic” products fit into car-
eer development, racism and discrimination, coping with
isolation as an URM faculty member, and receiving ad-
equate mentorship [5].
Very little has been published on keys to academic suc-
cess for URM young investigators in academic medicine.
The Academic Pediatric Association Research in Aca-
demic Pediatrics Initiative on Diversity (RAPID), funded
by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), is a research educational pro-
gram aimed at successful recruitment, retention, and pro-
fessional advancement of URM junior faculty in general
academic pediatrics who are pursuing research careers [6].
One of the most important RAPID components is the an-
nual mentoring and career-development conference,
which targets URM residents, fellows, and junior faculty
in general pediatrics, and has included 62 URM young-
investigator participants from across the country since its
inception in 2013 [7, 8]. A highlight of this highly rated
conference is the panel discussion on keys to academic
success for URM young investigators, which is conducted
by the RAPID National Advisory Committee (NAC)
members, who are a diverse group of leading senior re-
searchers in general pediatrics [9]. The objective of this
article is to address a major gap in the literature by provid-
ing a practical guide on keys to academic success for
URM young investigators.
Methods
The data source is the RAPID Conference panel discussion
from the 2018 Conference, which addressed six critical
questions: 1) What’s the single most important key to suc-
cess for a young investigator from a disadvantaged back-
ground? 2) How does an URM young investigator ensure
the best possible mentorship? 3) When you have a patient
or family who says, “I don’t want you to see my child be-
cause you are ____,” what do you do? 4) In these very chal-
lenging times for obtaining research funding, what are the
best strategies for maximizing funding success? 5) As an
URM investigator, how do you balance volunteering or be-
ing chosen to be on often time-consuming committees with
having enough time to advance your own research and car-
eer objectives? And 6) What is the single thing that you
wish someone had told you, which would have substantially
enhanced your success early on?
A modified Delphi technique was used to provide a
systematic approach to obtaining answers to these key
questions by leveraging a panel of experts [10]. The Del-
phi technique allows a group of geographically scattered
national experts to come together and provide and
synthesize knowledge, experience, and expertise on par-
ticular topics [10, 11]. The six questions were specifically
developed to identify the keys to academic success for
URM young investigators. These questions were piloted
in 2013 at the First Annual RAPID Mentoring and
Career-Development Conference, and further refined
during the subsequent four conferences, based on NAC
responses. After the completion of the 2018 panel, the
session transcript was provided to all NAC participants
in the second round of the Delphi technique. NAC par-
ticipants then provided feedback on or modifications of
their responses to the panel questions, and all NAC par-
ticipants reviewed the entire session to facilitate consen-
sus. Consistent with recommendations for the Delphi
procedure [10], the NAC panelists consisted of a hetero-
geneous group of experts representing both genders,
multiple races/ethnicities, and the spectrum of geo-
graphic diversity in the US. Additional details on the
NAC members are available elsewhere [9].
To summarize the overarching themes of responses to
each of the six questions, grounded theory was used to per-
form a thematic analysis and create a thematic taxonomy.
Results: RAPID conference panel findings: keys to
academic success for URM young investigators
The overarching themes of the expert panel’s responses
are summarized in Table 1. The following sections pro-
vide the specific, detailed responses of each panel mem-
ber to the six key questions.
G. Flores: What’s the single most important key to
success for a young investigator from a disadvantaged
background?
F. Jones: For me, the most important thing was having
mentors. Not just one, but multiple mentors. I didn’t
plan on doing academics when I first began my career. I
was in Milwaukee, doing a public-health loan obligation,
it was cold [laughter], the university offered me a job
back at Louisville, and I said, “okay.” So I had no idea
what I was doing. What got me through and kept me
going is mentorship. I still use multiple mentors today,
and I think that is exceptionally important that you find
mentors. Not necessarily one that’s assigned to you. Pick
them out, what you think you need.
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J. Raphael: Mentorship would have been my choice as
well. The other thing is write, write, write. You should
be writing constantly. It should be your default. You
should be constantly writing, because that’s the way that
you get into the habit of being scholarly, and the more
you do that, the easier it becomes, the easier you can get
Table 1 Taxonomy of themes in the responses by National Advisory Committee members of the Research in Academic Pediatrics
Initiative on Diversity to six questions on the keys to academic success for under-represented minority young investigators
Question Response Themes
What’s the single most important key to success for a young investigator
from a disadvantaged background?
• Having mentorship
• Having multiple mentors
• Write often
• Be strategic about your financial situation
• Negotiate well, especially regarding protected time for research
• Be passionate about what you study
• Get the right training and be confident about your ability to achieve
your goals
• Don’t view yourself as “disadvantaged”
• Be tenaciously persistent and “fail productively” (learn from each failure)
How does a young investigator ensure the
very best possible mentorship?
• Assemble several different mentors to address your multiple needs
• Don’t be passive: work hard to get what you need from your mentors
• Identify your future professional trajectory
• Ensure that your mentor has a proven track record for success
• Find a mentor who will invest in you
• Spend sufficient time with your mentors
• Make sure that your personality/style is a good fit with the mentor
• Have a mentor who also is a sponsor, with a clear investment in you
and your success
• Have at least one mentor who is a “coach”: able to provide honest
feedback, assist with achieving work/life balance, and facilitate
networking
When you have a patient or family who says, “I don’t want you to see my
child because you are ____,” What do you do? How do you react so that
the family gets the best care and you’re being ethical,
while protecting yourself?
• Seek to understand the reasons
• Exercise professional detachment
• Help the patient nevertheless
• Seek training about unconscious bias
• If the patient is medically stable, transfer her/him
• Hold open forums to discuss incidents and develop
coping strategies
• Protect and take care of yourself
• Debrief and process with trusted colleagues
In these really challenging times for obtaining research funding, what are
the best strategies for maximizing funding success?
• Use small grants to build your portfolio
• Seek non-traditional funding streams
• Leverage funding from mentors
• Write many proposals
• Collaborate with partners
• Network
• Strategically analyze the funder pay lines
• Establish a publication track record
• Negotiate protected time and resources in new jobs
• Participate in study sections
How does an under-represented minority balance volunteering or being
chosen to be on often time-consuming committees which, of course,
need diverse voices like yours, with having enough time to advance your
own research and career objectives?
• Using these opportunities to generate scholarly products
• Add such committee work to your CV and turn it into scholarly
products
• Choose committees strategically with the help of a mentor
• Join committees in the context of being an expert
• Developing a triage process based on interests and being politically
savvy
• Balance commitments with an eye towards promotion
• Prioritize activities that promote diversity and excellence
What is the single thing that you wish someone had told you when you
were a beginning young investigator which would have substantially
enhanced your success early on?
• Ask for all needed resources
• Identify what others negotiated for to determine the components of
competitive job offers
• Be focused
• Be open and seek advice
• Get outside your comfort zone
• Learn how to write well and often
• Focus on fulfilling your own standards of excellence, rather than
achieving external milestones and validation
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products out the door. And then it becomes such a great
habit: if you’re not writing, you start to wonder, “Is this a
good use of my time, because I know that career success
is going to be based on how well I write and get these
products out in a number of different ways. If I’m not
doing that and I’m not doing clinical work - because ob-
viously that is important as well - why am I doing what-
ever I’m doing?” And that helped me, because it was
advice somebody gave me, and I first thought, “I don’t
know how this is going to help me.” But over time, I
started to feel that tension. If I wasn’t writing, I really
started wondering, “Is this a good allocation of my
time?” So that really just helped me prioritize and think
about where all my efforts should be, and it made me a
lot more productive in the end.
J. Wang: I’m going to say something slightly different.
Perhaps not the most important factor, but definitely im-
portant, is early on, you have to be strategic about your
financial situation, because a lot of people can’t afford to
go into academics because of their financial situation. So
it’s good to plan early and make some really strategic de-
cisions about savings and investments, so that you won’t
end up with a lot of debt. People probably don’t tell you
that, but a lot of our decision-making is very simple. It’s
based on financial outcomes and it’s no different in this
group and many groups. It’s not the most important
consideration, but I thought I’d throw it out there for
people to consider.
I was going to choose mentorship, too, but besides
mentorship and writing all the time, one thing you need
is protected time, and a way to get that is negotiating
well. When you approach your first faculty position and
subsequent ones, make sure you have adequate pro-
tected time to do your scholarly work, whether it’s edu-
cation or research, and you always have to account for
your clinical time spilling over by 10, 20, 30% into your
protected time, because that’s just how it goes, and so
account for that. So, a 50% research position is not really
50%, it’s a lot less. Aim higher than that, if you can.
F. Mendoza: Two things: First, be passionate about
what you want to study. If you are passionate about a
topic, then studying will be more enjoyable, and thereby
more fun than work. I say this only because any aca-
demic pursuit will be time-consuming, and one needs to
have a short-term gain. Second, determine what you
need to do to have confidence in your work and know
that you are capable in your field of study. This usually
means having the appropriate training in the field and
bringing yourself to its cutting edge. By this I mean that
you know more about your topic than anyone else, be-
cause you have read the literature, linked with others in
the field, and thought about the important questions in
your field. All of us on this panel believe that all of you
are capable of achieving this goal.
M. DeBaun: I agree with everyone on the panel. I also
think it’s imperative to have a frame of mind that doesn’t
put you in the “box” of being disadvantaged. I’m not even
sure what that means. Fernando and I had this conversa-
tion last year; I never grew up thinking I was disadvan-
taged. I still don’t think I’m disadvantaged; I was not
raised to believe I am disadvantaged. I refuse to embrace
this concept that I am or was “less than.” I believe that the
single most important key step is to believe that you have
the same capacity to be successful as anyone else.
G. Flores: I would say the single most important thing is
to be tenaciously persistent while failing productively, and
by that I mean, Winston Churchill once said that, “Suc-
cess is going from failure to failure without loss of enthu-
siasm.” You have to learn to have a very tough skin. You
need to be productive with each failure. If you get a manu-
script rejected, use that as free advice about how to make
your next submission better. Same thing with a grant: If
you don’t get an award one year, put it in again the next
year and figure out a way to make it better. We’re sitting
right here in Silicon Valley, where having failures is actu-
ally a badge of success. People here say, “Yeah. Let me tell
you about my failures.” Because as Thomas Edison said, “
I have not failed. I’ve just found 10,000 ways that won’t
work.” You have to have that mindset to survive, and it’s
really about survival.
G. Flores: How does a young investigator ensure the
very best possible mentorship?
J. Raphael: One of the most important things is there’s
not a one-size-fits-all mentor. A lot of junior faculty strug-
gle with this, as I did. You want to find that person that
covers all bases. They are going to be your content expert.
They are going to be the person who fits how you think
about the world or how you orient yourself to the world.
They’re going to understand your methods and everything
else. But if you do that, you shortchange yourself, because
it’s nearly impossible to find that person. People struggle
and get frustrated within their institution because they
can’t find this amazing perfect mentor. What you learn
over time is that there are different mentors who can ad-
dress different areas. One may be great for research
methods, one for content, one for career. You really have
to decide how you want that layout to be so it more be-
comes a committee of mentors. The other thing is you
want mentors in your own institution, but outside your in-
stitution as well. Because your institutional mentors have
a little conflict of interest when it comes to certain things.
They may be a resource when you’re looking for another
job and talk with other people in the institution. So it’s al-
ways nice to have people external to your institution be-
cause those folks can look out for you in a different way.
They may have a conflict of interest as well because, cer-
tainly, they may say, “Why won’t you come here” [laugh-
ter]. But that’s a good thing [laughter]. Try to accept the
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fact that there is not one perfect mentor, and you need a
diverse array of people, internal and external.
F. Jones: You can’t be passive, because the mentor-
mentee relationship is an act of engagement. It takes a
lot of work. Have an idea of what you want from that
person, and have a contract, such as, “I would like for
you to do this, I will be doing this.” Make sure it’s a rela-
tionship, or you may not get as far as you like. It also de-
pends on the trajectory that you want. You have to
know what trajectory is best for you. If you say, “I want
to take the academic route. I want to work in an aca-
demic center, I want to be promoted in the clinician-
educator or tenure track,” then there are clearly compo-
nents of a mentor that you have to have. To put it sim-
ply, you need to be on PubMed to see whether a
potential mentor has published any manuscripts in the
last year. If not, then coming to their lab anticipating
you’re going to have six publications in the next year or
two is a non-starter. Because you’re not going to get that
person to all of a sudden be productive. That’s not the
way it works. Then, even if you see that they have 10, 12
publications a year, you want to drill down on, who’s
first and last author, because the mentor who’s last on
every publication is a signal. And the mentor who
doesn’t have fellows or junior faculty who are first au-
thors is another signal. So you really want to take a look
at that person’s track record. Last but not least, talk to
people in the lab. If they don’t plan to meet with you on
a routine basis, like weekly or biweekly, that’s not neces-
sarily an environment that you’ll thrive in, particularly
when you’re junior and you haven’t written your first
manuscript because you need that oversight and
support.
If you want to get a grant, there are NIH K awards, in-
stitutional K awards, and foundation grants. Almost all
award committees choose awardees, in part, based on
the mentor. So if the mentor doesn’t have a track record
of awardees who’ve been funded and doesn’t have any
funding themselves, be it HRSA, R01, NIH, or founda-
tion funding, then the likelihood of you being selected is
nil, because they’re going up against mentors who have a
long funding track record. If you have a great mentor or
junior person who doesn’t have that track record, the
suggestion is that mentor pairs up with a senior mentor,
and together, they write your letter of support. Because
we all were junior at one point. But it is a matter of
making sure that you understand what are the rules of
the game. And those are the rules of the game if you de-
cide to go the academic route and pursue the funding
ladder of institutional K, NIH K, or foundation award,
and then ultimately, independent investigator.
E. Fuentes-Afflick: The most important attribute is
finding someone who will invest in you. I wouldn’t get
personally caught up in what department they’re from.
I’ve been at UCSF since I was an intern, and when I was
seeking research mentorship as a junior faculty member,
my mentors came from internal medicine and OB. I first
did the rounds in pediatrics, but didn’t really find any-
one who had enough overlap or interest in mentoring
me. So I found two people in other fields. One is Dr. Eli-
seo Pérez-Stable, now the Director of the National Insti-
tute for Minority Health and Health Disparities. The
other was Dr. A. Eugene Washington, an OB who’s now
in a senior leadership position at Duke. Both had over-
lapping interest in what we now call health disparities.
We didn’t use that term at the time. But their interests
overlapped with mine, and that was our shared bridge. It
wasn’t because we were from the same clinical discipline
or worked in the same hospital or anything like that. So,
I would really encourage you to find someone who will
invest time in you and have enough of a shared interest
to make the relationship work, but not think it should
be this or that kind of person, because, really, the inter-
personal relationship is most important. And everything
that Michael said about the importance of choosing that
person is true, because a lot rides on that, but if you’ve
identified a mentor with a great name, but who doesn’t
really care about you, that also won’t work. It has to be
the mix of the right skills and interest in mentoring you.
J. Wang: I totally agree with Elena: Caring is the most
important mentor attribute. The other thing is, if you
have more than one mentor, think about their roles.
Some people are better at operations: helping you to
write a grant, editing, and giving you concrete com-
ments. Some people are better at strategy: overall vision
and career planning. Some people are better at enlight-
enment: work/life balance is very important. You need
all these things to be successful and have both a good
career and life. You want mentors that offer enlighten-
ment, strategy, and operations, and they might not be in
the same person.
J. Mendoza: Make sure you spend a lot of time with
your mentor and mentor committee. Make sure your
personalities click, that you actually look forward to
spending time with your mentor [laughter], or at least
look forward to getting feedback from your mentor and
making plans. You’re not going to become best friends,
of course, but you have to be able to have a good work-
ing relationship. Even among some of the most success-
ful scholars, sometimes, personalities just don’t work
out. So don’t force it just because they’ve published like
500 papers and have 10 NIH grants. It’s not worth the
conflict [laughter].
F. Mendoza: Do you know the difference between a
mentor and a sponsor? Raise your hand if you do. What
is it? Answer: A mentor is someone who provides per-
sonal and professional support in your development; a
sponsor is someone who goes beyond this and tries to
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connect you to other leaders in the field in order to help
you navigate your career path to success.
We talk about mentors, and everybody says that’s im-
portant. But as you heard, there are a lot of different
types of mentors. Clearly, you need to know what areas
you need help in, and to address those with mentors.
Sometimes, mentors can address more than one area. It
may be methodology, it may be career development, it
may be how you balance life, etc. But you also need to
have somebody that says, “I’m going to invest in you.”
That’s a sponsor. A sponsor is somebody that has, as
they say, skin in the game. The skin in the game is if
you’re successful, they’re successful. There are a lot of
mentors that mentor just because that’s their job to do
in the department. But they have no skin in your game.
They can say, “I mentored them, and it’s their problem if
they don’t get a job.” Or, “it’s their problem that they
don’t publish. Their lack of academic success is their
problem; they just didn’t have it.” So, having a sponsor is
key. A sponsor has to have an invested relationship with
you that goes beyond a typical mentorship relationship.
This invested relationship is what adds to their lives. Ba-
sically, the relationship between the sponsor and mentee
is that the sponsor is going to add to your life by making
sure you’re successful. And you’re going to add to their
lives by having them feel good because they made you
successful.
G. Flores: I would add that you want at least one
member of your mentoring team to be a coach, a su-
preme coach in the true sense of the word. What does
that mean? First, that they’ll be blunt with you when you
need some bluntness about, let’s say, your research really
isn’t up to snuff. Because even though that might ini-
tially hurt your feelings, it, in the end, will actually help
you. They also should be somebody who can help you
balance your work and personal life, as we often, in aca-
demia, ignore the latter. And if you don’t have balance,
then it’ll be difficult for you to be productive. And one
of the most important things, and I maybe didn’t learn it
well enough until later on, is make sure that that person
opens doors for you in terms of networking, whom do
you need to know, who are the key people in your field.
Can they connect you with somebody who can help you
with a grant, a publication, your K-award mentoring
team, or a future collaborator? That’s just so invaluable.
G. Flores: It’s been decades since we’ve seen this level
of racism, anti-immigrant sentiment, and bias in the US,
and it goes all the way to the leadership of our country.
It’s something you can’t avoid in daily affairs, and I’ve re-
cently come across a few articles about physicians who
have to confront racism with their patients and families.
When you have a patient or family who says, “I don’t
want you to see my child because you are ____,” what
do you do? How do you react so that the family gets
the best care and you’re being ethical, while protect-
ing yourself? Because that can be a really traumatic
experience.
M. DeBaun: I just want to tell a story that addresses
this point. I went to see a family of a new patient who
had just moved in from Alabama to Nashville, and the
mother looked like something inappropriate had hap-
pened. She was very closed mouthed, arms crossed, one-
word answers, and it was an odd interaction for a first
encounter with a family. Our clinic then had a family re-
treat four or five months later, and I invited the mother,
and made sure that she came to the family retreat with
her daughter. And she didn’t think I remembered her,
but I remembered her. I walked over to her, gave her a
hug, and said, “glad you’re here,” and then, “Remember
that time I saw you four months ago, and you were not
talkative, and you didn’t really respond? What hap-
pened?” She replied, “I’ve never had anybody black in
charge. I didn’t know if you were legitimate or not”
[laughter]. So, there is this idea that this oppressive
thought process only comes from the majority, but it
can also happen in the other direction, and so I carry
both with about the same weight. I seek to understand,
and then I move on, because, at the end of the day, I
know I have a gift to bring somebody when I provide
medical care for their child, adolescent, or adult, and
they can make a conscious decision to go elsewhere.
That’s their call, and I’m okay with them choosing to
seek care elsewhere. So if there happened to be a white
guy with a swastika on his forehead, and he has that
same reaction, I’m going to come in the room with the
same posture that I did for this mother, and then I’m go-
ing to ask him, maybe not in that initial visit, but even-
tually, I’m going to say, “What gives? Why do you have
this anger? Is it something I did? You had a bad day, but
I want to understand.” So I don’t see the two extremes
differently. I react in the same way.
F. Mendoza: When I was a young faculty member, a
first-year attending, there was a family who came in with a
child with asthma. They said, “I don’t want a Mexican
doctor taking care of my baby.” And I said, “Well, okay.
Let’s make sure your child gets good care.” But it was
funny, because it didn’t make me feel less, because I knew,
as Michael was saying, I’m a good doctor. I’m the attend-
ing on the pediatric ward at Stanford, well trained. In the
final analysis, as Michael points out, we’re professionals.
What does it mean to be a professional? It means that
you’re an expert, you know you’re an expert, and you deal
with a patient as a patient, not just the dynamics of the
physiology, but the dynamics of the background, politics
and all. That’s part of taking care of patients. Professional
detachment is useful in dealing with a situation like this.
At the same time, you can sometimes feel sorry for them
and their bigotry, but your professional role is to help the
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child, and if they see that, sometimes they apologize, and
they change. We’ve just finished some e-modules for
training on unconscious bias, both directed at patients,
and for patient bias toward physicians. It’s important for
us to start thinking about how to train ourselves to deal
with the various forms of unconscious bias. Because at the
end of the day, half of all kids in this country are minority,
and we’re seeing racism and other “-isms” out there. It’s
incumbent upon us not to degrade ourselves by moving
down to that level of bigotry, and to stand up here as pro-
fessionals, to say, “Look, we’re doctors. We’re well trained.
We’re here to help.” “If patients don’t want our care, then
they have the option to go someplace else.” At our hospi-
tals, if patients are hostile toward physicians or staff, they
can be transferred, if medically stable. Our hospital's lead-
ership have shown that they support a respectful work en-
vironment for our staff. Unfortunately, in our current
environment, we will need to deal with this, but we, as
leaders, need to stay professional, and we need to show
the light of caring. Martin Luther King said darkness
doesn’t wipe out darkness. Light wipes out darkness, and I
think we’re the light.
F. Jones: There have been a lot of articles about this
issue recently, and it does bring back memories of when
I was training. When I was doing my residency, this
family was adamant that they did not want me touching
their child, but my attending was there. He was a really
tall, white guy, former army, and his language was very
army-like. He spoke up for me. He was there to make
sure things were okay. So I remember that. For him to
speak up, it made such a big difference, and I make sure
I do that when I hear this same language. Because I’ve
gone into a room with another doctor, and they say hello
to the “doctor,” and tell me, you can pick up my tray.
But what you have to do, like Fernando said, is be pro-
fessional. Your goal is to treat the child, do the best you
can, and then you can deal with the other issues later,
but it’s nice to have an outlet where you can come out
with it and talk. At the University of Louisville, we pro-
vide open forums where we’ll discuss these incidents
and figure out strategies on how to deal with them. It
gives people an opportunity to express how they’re feel-
ing. It’s relief, and that’s what’s needed.
G. Flores: When I was in college, I took an ethics
course, and the one thing that stuck with me is, how do
you decide what’s the right thing to do? Basically, it
comes down to whether a neutral third-party observer
floating over the situation would determine that the ac-
tion that you took was the correct choice. So, the first
thing to do is what Michael was saying: see if you can
understand why. You may not get a helpful response,
but at least you can see if there’s something that you can
discuss and have a dialogue about. Second, you need to
make sure that the patient gets the care that that patient
needs; sometimes children are innocent bystanders. I’ve
heard two schools of thought, and I’m not sure which is
the right way. In some cases, some people believe that
the family who made the racist remark should leave the
medical facility, as long as the patient is not gravely ill,
and go elsewhere, because that’s not a philosophy that
the institution supports. Other people will say, “I’ll go
get a provider that you’ll be more comfortable with.”
Third, you need to “treat yourself” in that situation. By
that I mean, you need to process it and reflect about it.
Some people will write about it and then hopefully turn
it into a positive by teaching others, by sharing it with
your colleagues, by discussing how you deal with it, and
then producing a curriculum that we can provide people
with like yourself so that when this does come up, you
have a clear path. Because it’s easy to get angry, upset, or
hurt in that situation. What we want is what a neutral
observer would say was the right thing, that at the end
of the day, no matter how upset you are, that you feel
like you did the best as a human being in that very diffi-
cult situation.
M. DeBaun: You don’t want to respond to ignorance
with feelings of insecurity. When I started out, one re-
sponse to those situations was to ask the individual,
what medical school did you go to? That’s not necessar-
ily going to fight it or do anything -- now you’re becom-
ing insecure. Or sometimes you start to change how you
talk in response, and you say, “I’m going to talk like an
old person. I’m going to talk in this specific way,” and
you try to do all these things to overcompensate in the
moment, but that’s not the right approach. It’s what ev-
eryone’s saying: you want to stay in that professional
role. If you start to let yourself be affected, then you’re
not acting in the way that you typically do, and now the
child’s not getting the care that they should, because it
becomes more about you and trying to respond to that
ignorance in a way that takes you away from your pro-
fessional role and who you actually are.
G. Flores: I also want to make sure we address gender
issues, because even after we deal with the racism and
anti-immigrant sentiment, another current trend is
women saying, “We’ve had enough of this, so let’s assert
our rights and make sure that we’re heard.” If our panel
members have thoughts about how to address gender
bias when it comes up in patient encounters, we’d wel-
come your thoughts.
E. Fuentes-Afflick: In medicine, we’re really privileged
to have so many opportunities to grapple with those is-
sues, because when you deal with people every day, you
are a person, you work with a team of people, and then
you are interacting with people, and we’re often interact-
ing in a crisis or really difficult situations, which tend to
highlight any shortcomings we have. For me, one of the
most important issues is to try to be present in the
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moment, deal with what you need to do, but if you are
picking up on something, or someone says something,
handle the clinical situation, but take time during that
same day to debrief and process what happened, and
consider sharing with a trusted colleague, “This is what
happened, this is my interpretation. Do you agree? Do
you see anything else?” Because the more we can deal
with bias or differential treatment in real time, it’s always
going to be better than accumulation and then eruption.
It’s also important to recognize that we all have our sen-
sitive points, and someone might say something and it
may be intended in the way that you interpret it, or it
may have been intended in a different way, if you look at
it from a slightly different perspective. Not, of course,
every statement falls into that category, but sometimes
that does happen. If you have trusted colleagues with
whom you can debrief and discuss and then make a plan
of correction or a plan to move forward, that’s always
helpful. I work at an institution where we’ve got all signs
everywhere, all races, all colors, all this, all that. But you
can never control what happens between two people or
in an interpersonal setting, and sometimes, things happen
even with all of that signage. I think it is our responsibility;
we cannot walk away from a clinical issue, even if the
person is very upsetting to us, but we do need to figure
out how to deal with that after the crisis has passed.
F. Mendoza: Changing culture occurs because we
recognize something and we talk about it, not just those
of us of color, but everybody talks about it. You are in
positions where you’re supervising residents and medical
students. The lowest person on the totem pole is a med-
ical student, and they sometimes come to us as deans
and say, “This happened and nobody said anything.” I
interview internship applicants, and ask them if they
have experienced these kinds of things. Our culture right
now doesn’t address this; it sweeps it under the rug and
leaves it up to the individual. If we want our hospitals to
be better, we need to talk and teach about these issues.
We need to allow trainees and colleagues to say, “Here’s
what’s happened.” Or you may want to be preventive by
saying, “Sometimes, on a clerkship, this may happen.
Here’s what I want you to do.” That’s the preventive and
proactive way of saying, “Our culture is a culture of ac-
ceptance, professionalism, and focus on kids’ health, and
here’s how we’re going to accomplish this goal.”
G. Flores: For the next question, we’ll “switch gears.”
In these really challenging times for obtaining re-
search funding, what are the best strategies for maxi-
mizing funding success?
J. Wang: Since we’re in Silicon Valley, I’m going to talk
about some strategies that people use here for startups,
and an academic career is no different than a startup. If
you think that way, how do you try to build a career,
and get the initial pot of money, and grow that money?
Traditional sources of funding are drying up. So it’s ap-
propriate to use the word, “bootstrapping.” You know
how a lot of companies here do startups; they initially
have some idea, and they’re still working for other
people, but they try to have allocated time when they
focus on what they want to do while still working for
the company. And then, they try to bootstrap a little bit
of money here and there, and try to build from small
projects. Right now, it’s so hard to get an academic job
right out of training. So maybe you need to bootstrap
and focus on one or two key ideas and apply for small
grants, and slowly build that up into a body of work with
which you could convince people to invest in you a big-
ger pot of money, which is no different than a startup.
It’s like lean startup. You hit certain milestones, people
invest more in you, and then you hit another milestone,
and people invest more. I’d be a little entrepreneurial at
this moment.
M. DeBaun: I didn’t know this at your stage, until I
got to my stage and understood the game. This strategy
that I mentioned earlier about looking at the funding
record of your mentors is important, because they have
discretionary funds. So, when you find a mentor that
meets all the criteria that we talked about - compatibil-
ity, and so forth – but, also, the funding, then they can
pay for the statistician that you don’t have the money to
pay for. They can send you to New York to give a talk
and meet with other people in the same sphere, and you
don’t have to say, “I can’t afford to go.” They can take
you on a trip abroad to work with the colleagues who
are international experts. These are all the intangibles
that I saw with my eyes wide open when I became a pro-
fessor, but didn’t know when I was an assistant professor
or a fellow. So, it’s not just about choosing the mentor
who has funding, but the funded mentor willing to in-
vest and be a sponsor. It’s a very important component:
having access to resources through your mentor. When
the K-award committee makes selections, the reason
they want your mentor to be funded is because it’s been
worked out for several decades that this is how junior
people become successful. It’s because their mentor has
been willing to invest in them, and they specifically state
that there should be resources that the mentor will aug-
ment for the mentee’s career trajectory in their scientific
proposal.
At the same time, you have to write. I don’t mean just
manuscripts; you really have to write grants. If you’re
not writing a minimum of three to four grants a year—I
couldn’t care less if it’s to the local Presbyterian church
down the street that’s interested in health disparities—
you have to write. Fernando and I had this wonderful
conversation yesterday, about how, after submitting so
many grants that did not get funded, we used those as
learning opportunities, and the light bulb finally turned
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on for both of us, like, “hey, I’ve now had my 100th
grant rejection, my 101st got funded, and I feel like I
know how to do this.” So there’s no shortcut to hard
work. You really do have to fail a lot. You really do have
to write a lot, and so set a bar and just write and write
grants. Not just manuscripts.
F. Jones: I’m going to be out of the box because I don’t
usually go for NIH funding. Because my work is more
community- and diversity-related, so you think about
who’s interested in that and how to put things together:
in a professional, totally dynamic team that may not
have worked together before, from multiple disciplines
that will affect the community. So looking at opportun-
ities in that way. That may be through city government,
state government, or foundations. You look at those
kinds of things and cultivate those relationships. I do like
to work, when possible, with a grant writer. We don’t al-
ways have that available and we have to do it ourselves,
but if you can get that input, it’s exceptional. In our of-
fice, we have a small group of people, but lots of part-
ners. And that’s how we put things together: through
partners, and figuring out how we can put a proposal to-
gether to get the things that we want.
J. Raphael: Another important thing is maintaining all
these collaborations that you have, either at the local or
national level, because those may be the people who say,
“you’d make a great person to have on our grant and
provide this type of expertise.” So in addition to having
that phenomenal resource mentor, look at other people
in networks who may be doing things. That means get-
ting out there at your typical meetings at the hospital, in
medicine, and at conferences. Because those opportun-
ities will come up. One thing to balance is, if you’re go-
ing to be on someone else’s grant, you have to think
about “what is the minimum effort you need to be pro-
ductive?” Because Jay and I were talking about this
“death by 5%” earlier [laughter]. It’s that not all funding
is good funding, in the sense that sometimes you might
get a small piece. But then that person may ask you to
do a lot more than that. So now you’re really tied up
with a little bit here, a little bit there. You have your bi-
weekly meetings for those grants, and before you know
it, you don’t have your own career, your own thing, your
priority. So you want to go after where the funds are,
but in a methodical way where you still can achieve suc-
cess and conduct the research you want to do. Because
there is going over the edge, where you just have all
these little things, but then they’re outstripping the time
that you actually have.
J. Mendoza: I have some more practical advice. For
those of you who are going to become clinician-
scientists, you’ll be looking to the NIH for a K award. It
would be wise to examine the pay lines for K awards for
the various NIH institutes that you are considering,
since some have more favorable pay lines than others, as
well as larger budgets. So keep that in mind. Many of
our colleagues have built their careers on obtaining
funding from smaller institutes, and they do great. It can
be more difficult to crack that egg now, because funding
is so tight. For example, I have obtained funding from a
variety of NIH institutes for my research on inequities in
youth physical activity and nutrition. For those of you
looking to bridge your way to a K award, go for those
small grants. Also look at diversity supplements for your
mentor's existing R01 grants. There are creative ways to
build your career up to that K Award. And once you get
that K Award, it’s kind of like a golden period where you
have four or five years of protected time. You may not
write three or four grants every year during that K award
because you’ll have to actually do what you said in the K
Award. So that will be a unique time in your career
where you’re not writing as many grants. Once the K
Award is halfway finished, you will be writing three to
four grants yearly. And that’ll just kind of be of how
your career goes, unless the golden age of NIH funding
comes back to us [laughter], which doesn’t seem likely.
M. DeBaun: Jason said something that’s not intuitive,
and I didn’t know what Jason just said when I was at
your stage. You can go to the NIH website and look at
the funding for each institute. Within the institutes, they
tell you how many grants they give for each funding
level. The K type Award (mentored award) is a special
funding pool. For junior faculty in this room, it would
be a K23, so you would look specifically for how many
K23 s were awarded by each institute. You really have to
spend some time looking at the data to have a handle on
what was just said. And within institutes, they have a
pay scale. They tell you, “we fund at the 15th percentile,”
or “we fund at the 20th percentile.” Last, but not least,
the best time to write a grant is when you don’t need it.
Don’t wait until Year 4 of your K award to write your
first grant since you received your K23 award, because
there’s an acquired skill to writing successful grants. So,
I respectfully would say, write as soon as you can.
E. Fuentes-Afflick: Remember that societies and other
organizations often have travel awards. They have Young
Investigator Awards. They have different categories of
awards, and even if the amount is small-- as Jason was
saying, bootstrapping, right, a little this, a little of that.
What Jay said is important, because “a little bit” is not
always a little bit of work. But keep your eyes open for
those kinds of opportunities, especially for travel and
presentation at conferences. Many institutions also have
internal travel awards. If you have an abstract accepted,
then you’re eligible, perhaps, to apply for funds that will
help support your travel. The only caveat I would add to
what Michael said about mentors having discretionary
funds is that everyone is feeling the squeeze, including
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mentors. So that’s often true, but maybe not as true as
you would want it to be. Just keep an open mind about
all the various sources of funding. The other point that
Jean made that’s really important is networking. Invest
in the relationships that you have here today. It certainly
happens for us at the mentor or faculty level, because
people come in and out of your life in ways that will sur-
prise you, and the last thing you want is for someone to
remember you as rude, arrogant, or not dependable, be-
cause that will haunt you for a long time. But if you
show up, you’re collegial, “Hey, how you doing?”—that’s
the kind of relationship and reputation that will defin-
itely help you.
F. Mendoza: Make sure you connect with Elena. She’s
the president of the American Pediatric Society, which is
the senior society for academic pediatrics. Let me bring
this together a little bit. I’m on the Advisory Council for
the National Institute on Minority Health and Health
Disparities. All these councils want successful minority
candidates. What does that mean? Certainly, all the
things you heard is important. But at the end of the day,
you have to show that you’re a scholar. What I tell my
mentees is, if you write one paper, that’s great. If you
write a second paper on that topic, people note, “you
wrote a second paper.” If you write three papers on the
same topic, then you become an expert. At the end of
the day, it’s important to focus on what’s important to
you, but also know how to write and get published. If
you submit a grant for which you can show these types
of accomplishment, three papers on the same topic, a fo-
cused research topic, access to good mentorship/collabo-
rators, you’re more likely to get funded.
G. Flores: I would add that you want to set yourself up
from the beginning for success. By that, I mean, when
you negotiate for your job, get as much protected time
as you can. Get seed money; it’s perfectly reasonable to
ask for some funds upfront to do your research. Make
sure you have, as was mentioned, at least one of your
mentors who has a solid, established NIH or AHRQ
funding record. One of the best ways to learn how to
write a grant is to be on a study section. And that can
be internally. It can be NIH; sometimes they’re looking
for young investigators, particularly with some diversity.
And, as mentioned earlier, look for other bridging grant
sources. Of course, the RAPID award is a great one. And
then I want to remind you I’m on the National Advisory
Committee for the Harold Amos Medical Faculty Devel-
opment Program, which will consider every kind of re-
search, from basic science on up to health services
research. Dr. Debaun, I believe, is an alumnus, as am I.
And you can hold one of those at the same time as a K
award. So have a look at AMFDP.org.
E. Fuentes-Afflick: You’ll notice from the Pediatric Aca-
demic Societies or the Academic Pediatric Association,
there’ll be calls for abstract or workshop reviewers. Even if
you think, “ I don’t have a lot of expertise,” you can re-
quest a specific area you want to review in. And it also
gives you a bigger sense of how people write, and how you
fit it into that abstract box. Now you’re scoring and con-
tributing to the quality of the meeting, but that’s also an-
other way to get a toehold into this reviewing-as-learning
process. And it’s hard to get onto a study section or grant
review process until you have a little more of a track rec-
ord. But the lower-stakes abstract review is really easy to
just sign up for and be a part of.
G. Flores: Next question: how does an under-
represented minority balance volunteering or being
chosen to be on often time-consuming committees
which, of course, need diverse voices like yours, with
having enough time to advance your own research
and career objectives?
F. Jones: Being black and a woman, I count for two
things, and I’ve been told that when I get put on com-
mittees. You’re two marks that they can check off. And
it’s amazing how many committees and everything else
that people want me on. So what I have done in order
to accommodate the things that I like and do all these
other academic activities as expected of me, I use that
for some of my scholarly activity. Using the things that
happen with those committees or things that we want
to do, we can write about it, and do something with it,
and use it as scholarly activity. So it helps balance
things out a little bit.
E. Fuentes-Afflick: If you think that your perspective is
important, or you represent some bigger group, and
you think that that perspective is not well-represented
around the suites of power, you have to show up. You
have to talk, you have to sit in the chair, and you have
to do the work to represent that. So it’s not fair to think
it’s someone else’s responsibility to represent that per-
spective because you’re too busy doing other things. So
I like the approach that Faye raised in terms of convert-
ing that experience into something scholarly, into
something more. Although, make sure that your CV is
your friend. We have an online system at UCSF. Every-
thing that you do, put it on your CV. You’re mentoring
someone, you’re attending this conference, put that on
your CV in terms of national conferences that you’ve
attended. Everything needs to count, because if you try
to update it once a year, you’ll forget things. But if you
do it as you go, then it’s easier. But I feel like there’s no
substitute for participation and showing up. In some
ways, it becomes a virtual circle, because then you have
a reputation for being involved and sharing a perspec-
tive, and that can lead to other things. It may not be
what you thought it was going to lead to, but it does
help, and as scholarly as you can make it along the way
will be to your benefit.
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J. Mendoza: I’ll go back to my early career days, when
you struggle to just exist, like you need to justify your
existence at the institution. You need to get that K
award or whatever it is that you need to get. So you’ve
entered academia, you still need to do service. The thing
you can be strategic about it is, with your mentor or
your mentoring committee, you can pick and choose
what you take on, and going into it, you should know
how many hours of meetings are needed and how much
work is required outside of those meetings, because,
again, that can bleed into your protected time. And once
you reach associate professor, once you become more
well ensconced and feel more comfortable at your insti-
tution, then you can really shine, get out there, and serve
on multiple different committees, if that’s your desire
and where your heart is. But when you’re early-career
faculty, you’re at a very vulnerable time, and so I would
be strategic. Yes, you need to serve, but it shouldn’t
overtake the rest of your academic time.
J. Raphael: It’s such a tough situation, because when
you start at the institution, you want to contribute to all
these different ways. Some people call this the minority
tax. It’s tough because, sometimes, you do these activ-
ities that are more along the lines of volunteerism; it
may feel good to talk to a school from 9:00–10:30, but
after you’ve done that four times, that’s a lot of papers
and grants that didn’t get written. Then you feel guilty
and start thinking, “What was the impact of what I did?
What was really good?” So what I came up with over
time for myself is, I do want to be that person at the
table, but I’d like to do it in light of being an expert, be-
cause you have more credibility that way. Because if you
just become the minority person on all these commit-
tees, you won’t get the respect, because you don’t bring
expertise to the table if you’re not accomplished in some
way. If you become that amazing medical educator, you
can speak in a way that no one else can. If you become
that amazing researcher, your words are taken in a dif-
ferent light. For me, it was go out, develop your track
record, and then you can speak. Once you get to that
point where you become an expert, you don’t just have
to be the minority person at the table. You’re actually in
a completely different position, because you’ve earned it
in a different way, and people are going to respect more
what you have to say. It’s not like this is a person we put
on all these committees. This is the person who is now
the Dean for Research, the Vice Chair. All the accom-
plished people here, they’re doing it in those different
facets. They’re not doing just because they have to. If
they do it, they’re doing it in a very vigorous way where
they’ve done the training and have the time allocated.
They’re not just doing it without thinking of strategy. It’s
a hard thing that you struggle with as junior faculty.
What I would always say is just go back to what your
expertise is. Think about what you want to be, and come
to the table as that person, not just the person who’s be-
ing the activist for the institution, because if you are, I
just don’t think you get as much respect.
G. Flores: Develop a triage process. Is it something
that you’re really interested in? Because if you have a
passion for it, then, by all means, do it. There are some
requests that you have to do. If you’re department chair
or division chief or the dean says, “Camille, I’d really like
you to be on this committee,” you have to make sure
that you are politically savvy and do things that people
feel you should be doing. And then there may be situa-
tions where you feel like you can’t do it. At a junior
level, the smartest thing to do is not just to say, “no.” It’s
also helpful to go to that good mentoring team that you
have and say, “I don’t know if I can do all this. What do
you think?” And hopefully, they can run interference for
you or tell you a way to navigate through the system.
F. Mendoza: One should always strive to obtain a bal-
ance of participation in “minority” activities and doing
your academic work—but a balance with the goals of
making sure you get promoted to associate professor
and that you are an academic leader. When I started in
1981, there were 0.5% Mexican-American faculty in the
whole country. Thirty-five years later, it’s at 0.6%. The
problem is that many young minority faculty don’t make
it. They do things that don’t get them promoted, while
other faculty do only things that move them toward pro-
motion. Yet, one thing you have to take into account in
your “balance” is that you’re also becoming as an aca-
demic leader, not infrequently in an area of diversity.
Even if you’re not a minority, academic leaders are look-
ing to promote those people that are good scholars, but
also have leadership. So, this is where assessing your bal-
ance between participation in activities outside of your
research is important. And this is where you have to de-
cide where your balance lies.
M. DeBaun: I want to make this concrete, because,
sometimes, we give you these good ideas, but there not
concrete. Christian interviewed at Vanderbilt. And he
had a second-look day. I’ve never attended a second-
look day at Vanderbilt for pediatrics. But every year for
the last seven years, I’ve mentored a medical student at
Meharry Medical College, a Historically Black Medical
School, or medical students from Vanderbilt. And some
of the medical students have gone on to get competitive
funding for one-year pull-out competitive programs,
such as the Doris Duke Charitable Foundation or the
American Society for Hematology. So, you can see I’ve
made a conscious decision. I have asked myself, how am
I going to spend my effort to promote diversity and ex-
cellence? I’m not going to spend my effort on a feel-
good moment. And I’ve rejected this approach for pro-
motion for a long time [laughter]. But at the same time,
Flores et al. International Journal for Equity in Health           (2019) 18:93 Page 11 of 15
I’ll move heaven and earth for the medical student who’s
at a Meharry medical college across town to make sure
that they get the same opportunity to pursue research
that Vanderbilt students have at Vanderbilt have to work
in my laboratory. You have to make a personal decision
about what’s important to you, and then just go with it
and don’t look over your shoulder.
G. Flores: What is the single thing that you wish
someone had told you when you were a beginning
young investigator which would have substantially
enhanced your success early on?
J. Raphael: I would honestly ask for the resources that
you need. Because once you take a position, it’s hard to
suddenly negotiate and say, “I suddenly need a research
assistant. Or I need a statistician. Or I need a research
coordinator.” You have to become a good negotiator.
And part of that is asking for the things that will allow
you to be successful in your early life as a junior investi-
gator. If you don’t, then that becomes very problematic.
I wish someone had been more forceful in pointing that
out to me in the beginning.
J. Mendoza: Finding out what your peers are getting in
terms of competitive offers being made: what should you
expect in a package, how much protected time, those
kinds of things. That’s very important information. The
institutions may not want you to have that because it
will be to your advantage during negotiations. I wish
there was a more systematic way of spreading that infor-
mation around, but y’all are pretty smart, you might be
able to figure out how to do that. Just having the infor-
mation at hand is very important.
J. Wang: This is a very hard question. Because you
can’t do a controlled experiment on life [laughter]. So
it’s difficult to know if you’d do it differently. I wish
somebody told me early on to focus—not to be involved
in a million things, just to focus on a few things. Then,
given limited time, limited resources, you’re probably
going to be more productive. It depends on the person-
ality of the person. If your talent is to go across, to make
connections in different ways, then it’s probably the
wrong advice. But in general, for academia, everyone
tends to be very focused like the NIH institutes. All the
reviewers are very focused, so to play the game, you have
to be focused.
E. Fuentes-Afflick: It’s a really hard question. Person-
ally, I don’t have many regrets. Starting off from a more
negotiating perspective is good, but at that time, for me,
it was clear that my department felt like they were taking
a chance on me. And I didn’t have protected time. I
didn’t have a lot of other resources. Try to be open and
seek advice. We’re often reluctant to say, is this enough
money? We’re often very private about that and for good
reason. But to the extent that you can benchmark what
you’re being offered will be reassuring and helpful. But
you’re in a vulnerable negotiating position. Also, don’t
go in thinking you’re an all-star and you’re going make
an all-time record. You have to be just a little careful
that you don’t overplay it.
F. Jones: For me, it’s getting outside of your comfort
zone. When I first started, I was very focused, and stayed
right within my lanes. But to really do something in-
novative and impactful, you have to get outside your
comfort zone.
M. DeBaun: I was naively trusting of the system that
all faculty recruits on the tenure track were given an
equal shot for success and similar resources to begin
their career. Not until I started to mentor other faculty
did I realize tenure-track faculty were not all offered the
same opportunities when they were recruited. In my first
faculty position, I did not have a start-up package, even
though my salary was fully funded, at greater than 90%,
and I was on a tenure track. Perhaps the absence of a
start-up funds was a good thing for my career. I had to
focus my energy. I didn’t have the luxury of spending
time on projects that were not going to lead to my next
grant. But later in my career, I had a moment of clarity
when I learned that other tenure-track junior faculty re-
ceived start-up packages to improve the likelihood of
success. The bottom line is, I would make sure that as a
new faculty recruit, wherever you go, you receive more
than a vote of confidence in your career, but also re-
sources commensurate with your peers. You should also
have access to close mentorship and resources on par
with your peers to increase your likelihood of success.
F. Mendoza: I was the only minority faculty in 1981 in
my whole medical school. And then I became a dean
two years later. Looking back, what would have helped
is to have been told, “learn how to write, and write well,
and write often.” It took me a decade to do that. My first
grant was in 1992. I’ve had 25 years of grant funding. I’m
a better writer now. I don’t know that I’m a great writer,
but I write better. I went into science because I didn’t
like English [laughter]. But at the end of the day, I have
learned that you are in academia what you write. And all
these other things will happen if you learn how to write,
write well, and write often. Moreover, today, there’s a
need to speak for people that can’t speak, that is, for our
communities that don’t get to be part of the public dis-
course. It’s through writing that we can help speak for
them.
G. Flores: My advice would be, don’t let external mile-
stones define you. By that, I mean, it’s easy to get caught
up in, “if only I had had that award for career contribu-
tions, or if I only had that 200th publication, or if I only
had that $5 million grant, then I would be successful,
and I would be in heaven and achieved everything I
needed.” It really should be about what John Wooden
once said. John Wooden was probably the greatest
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college basketball coach ever. He broke all the records
for consecutive NCAA championships, and someone
asked him, “What drove you? Was it trying to break all
the records?” He said, “No. Success is peace of mind,
which is a direct result of self-satisfaction in knowing
you did your best to become the best you are capable of
becoming.” And I thought about that and I said, “Oh,
come on, it’s got to be all those awards. That’s a great
thing to have.” But it really is true. There’s no greater
sense of satisfaction than fulfilling your own standards,
saying, “I have a goal. I want to be an expert on uncon-
scious bias, or disparities,” or whatever it is you’re work-
ing on, “so that I feel like I achieved the goals that I set
for myself.”
Dr. DeBaun mentioned that a lot of people didn’t tell
him what he should have known as a junior faculty com-
ing in, so I want to ask the panel, “How do you ask that
question when you’re going to a new institution, es-
pecially if there are not a lot of people ahead of you?
What should I be getting? How do you approach
that?”
M. DeBaun: There’s an inherent conflict, if the person
you’re negotiating with is your mentor. You have to
understand that you need an advocate outside of your
mentor. And we’ve talked about these mentors: there’s a
career mentor, there are peer mentors. And we haven’t
said that enough. But you all will hopefully form peer
mentorship, and you will be the best source of, “Well,
what did you get? How did you negotiate this problem?
How did you figure out, ‘hey, no, I don’t want more
money for my start-up, I need a higher salary.'” Or you’ll
find out that some people get their loans repaid. So you
really do want to form these mentorship teams: career
mentor in terms of your science, professional mentor-
ship, someone in a different institution that you can have
an offline discussion about your negotiation package,
and then peer mentorship being people who are walking
through the same steps you’re walking through so you
can get their feedback.
E. Fuentes-Afflick: If you’re going to a new institution,
try to use your network to say, “Do you know anyone at
this place? Because I’m considering a job and I don’t
have enough context to be able to interpret the offer that
they’re making me.” Maybe that person can say, “My
friend Jason is at Stanford. Let me contact Jason and see
if he’d be willing to talk with you.” That’s also how you
can leverage networks to help you. Not that Jason is go-
ing to advocate for you, but he might say, “Right now,
everyone is getting 10% protected time; we’re just in a
time of fiscal constraint and that’s really what we can
offer.” So, it’s not different than what I’ve seen for other
people, but it’s tough. With that information, you’ll feel,
“Okay, my letter is consistent with what other people
have been receiving.” So, use that network to try to plug
into someone, but you also have to be comfortable. As
Faye was saying, reaching out of your comfort zone, con-
tacting someone who you don’t know, trusting that if
someone connects you to someone, then you have to
make the next step. People are not going to put it on a
platter for you. Make sure that you feel comfortable.
Also, reach out with a specific request. Again, not best
friend forever and not going to bat for me, but just, I
need a little more information so I can interpret this op-
portunity because I’m really excited about X, Y, and Z,
but I have concerns about A, B, and C.
F. Mendoza: Know the rules of the academic game,
and all your questions should focus on, how do I get
promoted? You can get people to help you understand
the process, but you have to know clearly what it takes
to go from assistant to associate professor. You should
ask your division chief, the person that’s going to be hir-
ing you, or the person that you’re working for in that in-
stitution. You should talk to the department chair and
sometimes also the dean of academic affairs. If all three
points of view on promotion line up, then you will know
what exactly you need to get promoted to associate pro-
fessor. I’ve seen situations, however, where each of those
people relate different things. In that scenario, you’re
stuck. A few years ago, a faculty member who was a
neurosurgeon said to me, “My department chair said
that I should do a hundred cases a year and teach, and
now I’m going to be up for tenure, because he thinks I’ll
get promoted.” I told him that I was concerned because
he had not published. This a case where someone did
what his chairman said, but the information he received
about promotion requirements was not totally accurate,
and consequently, he was left in the difficult position of
possibly not being promoted. So, just make sure you
know what you need to do to be promoted, because
then, things are more likely to fall into place for you and
your career.
F. Jones: The other important part that you need to
look at for any institution that you’re going to is what’s
the climate’s like, because it may all look really nice on
the surface with people getting promoted, but when you
look at the climate hard, are the underrepresented fac-
ulty getting promoted at the same rate as everybody else.
All of those things are important, so dig that informa-
tion out. One simple thing I did several years ago is to
actually talk to people who left the institution. That can
be very informative, because sometimes those individ-
uals will say, “the reason I left was to be closer to family,
” or something else. Or, they may say, “this is something
very specific to this institution that I did not like.” Some-
times, you have to take those things with a grain of salt.
But this is a business decision, so if I’m going to invest
here, what would I do? Talk to the people at the com-
pany. I’d talk to people who’ve left the company, so that
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you cover all the bases and get the information you
need. The other thing is, you get in front of that person
that’s your mentor, they’re not looking at you as their
mentee right now. They’re looking at you as an item on
a spreadsheet that they want for the cheapest price pos-
sible, and you’re like, “but you’re my mentor,” or, “you’ve
been this amazing person.” That’s gone in their mind,
and your feelings will get hurt. You will compromise
your future stability if you look at them as your mentor
in that moment. So, if you’re going to negotiate with
them, it’s got to be all business.
J. Wang: Negotiating with any institution, it’s like buy-
ing a house. If you’re going to move to an area and buy
a house, you want to know what the average housing
price is. Those data are published for every single spe-
cialty by region: average salaries for assistant and associ-
ate professor. So, you should get hold of that, or the
department chairs have them. The other thing is that
you should know what you have. If you go to go buy a
house, you should know how much cash you have, how
many loans you have, and what your credit score is. It’s
the same thing with a job: you should know if you’re
bringing in funding, if you’re going to need support, and
if you have a good track record that’s almost like your
credit score. You don’t walk into a negotiation without
knowing what the average market conditions are and
what you have to bring to the table. And after you do
that, it’s always good to have an advocate, so you don’t
directly go and ask. Maybe you asked for an advocate
who could answer on your behalf. So, it’s not a yes or no
question, but, “how can I do this?” There’s a book on
getting to yes, and one on getting past no. So, just read
those two books. [laughter].
Conclusions
This is the first published practical guide (to our know-
ledge) on keys to academic success for URM young in-
vestigators. The NAC panel of leading senior pediatric
researchers identified the following keys to success for
URM investigators: having multiple mentors, writing
prolifically, being strategic about your financial situation,
having a passion for you research topic, confidence
about your capacity for success, and being tenaciously
persistent. Advice on ensuring the best possible mentor-
ship included having different mentors for different pur-
poses, taking an active role in getting what you need
from mentors, choosing mentors who have track records
of success, having mentors who are invested in you,
identifying mentors who are a good fit, having a mentor
who also is a sponsor (able to connect you to other key
leaders in the field), and having a member of the men-
torship team who is a coach.
NAC panelists’ advice on dealing with families who do
not want you to care for their child because of your race/
ethnicity included seeking to understand the reasons,
transferring the patient to another institution, having a
faculty forum about the issue, making sure the patient gets
needed care, taking care of yourself emotionally, debrief-
ing with colleagues, and turning it into a positive by writ-
ing about it, teaching others, and developing a curriculum.
Panelists’ guidance on maximizing funding success in-
cluded seeking non-traditional funding streams, building a
portfolio of small grants, leveraging funding from men-
tors, writing many proposals, working with partners, net-
working, strategically analyzing the funder pay lines,
establishing a publication track record, negotiating pro-
tected time and resources in new jobs, and participating
in study sections.
Regarding balancing committee work with having enough
time to advance one’s research and career, the panel advised
using these opportunities to generate scholarly products,
adding such committee work to your CV, choosing com-
mittees strategically with the help of a mentor, joining com-
mittees in the context of being an expert, developing a
triage process based on interests and being politically savvy,
balancing commitments with an eye towards promotion,
and prioritizing activities that promote diversity and excel-
lence. The most important things that panel members
wished someone had told them when they started out as a
young investigator included asking for all of the needed re-
sources, identifying what others negotiated for to determine
the components of competitive job offers, having focus, be-
ing open and seeking advice, getting outside your comfort
zone, learning how to write well and often, and focusing on
fulfilling your own standards of excellence rather than
achieving external milestones and validation.
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